Evidence map›Paper›PMID 34208489›Full record

ReviewVaccines2021

An Antigenic Thrift-Based Approach to Influenza Vaccine Design.

Jai S Bolton, Hannah Klim, Judith Wellens, Matthew Edmans, Uri Obolski, Craig P Thompson

Open access · goldAbstract readReview
In one paragraph

Review in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Jai S BoltonPeter Medawar Building for Pathogen Research, Oxford OX1 3SY, UK.ORCID 0000-0002-6738-7823
Hannah KlimPeter Medawar Building for Pathogen Research, Oxford OX1 3SY, UK.ORCID 0000-0002-7655-6449
Judith WellensPeter Medawar Building for Pathogen Research, Oxford OX1 3SY, UK.ORCID 0000-0002-1647-8151
Matthew EdmansPeter Medawar Building for Pathogen Research, Oxford OX1 3SY, UK.
Uri ObolskiSchool of Public Health, Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.ORCID 0000-0001-7594-9745
Craig P ThompsonPeter Medawar Building for Pathogen Research, Oxford OX1 3SY, UK.
University of Oxford · GBTel Aviv University · IL

Funding

BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES: SARS-CoV-2 ACTIVITIES75N93019C00076 · NIAID · UNIVERSITY OF CHICAGO · PI STEVENS, RICK · 2019 to 2023
$32.6M
NIAID NIH HHS 75N93019C00076
6 · The paper itself

Abstract

The antigenic drift theory states that influenza evolves via the gradual accumulation of mutations, decreasing a host's immune protection against previous strains. Influenza vaccines are designed accordingly, under the premise of antigenic drift. However, a paradox exists at the centre of influenza research. If influenza evolved primarily through mutation in multiple epitopes, multiple influenza strains should co-circulate. Such a multitude of strains would render influenza vaccines quickly inefficacious. Instead, a single or limited number of strains dominate circulation each influenza season. Unless additional constraints are placed on the evolution of influenza, antigenic drift does not adequately explain these observations. Here, we explore the constraints placed on antigenic drift and a competing theory of influenza evolution - antigenic thrift. In contrast to antigenic drift, antigenic thrift states that immune selection targets epitopes of limited variability, which constrain the variability of the virus. We explain the implications of antigenic drift and antigenic thrift and explore their current and potential uses in the context of influenza vaccine design.

Indexed as

antigenic driftantigenic thriftevolutionary theoryinfluenzavaccinationvaccine

Identifiers

PMID34208489
PMCPMC8235769
OpenAlexW3166071607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.